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Abstract
Background: The mammalian target of Rapamycin (mTOR) kinase plays a key role in translational control of a subset of
mRNAs through regulation of its initiation step. In neurons, mTOR is present at the synaptic region, where it modulates the
activity-dependent expression of locally-translated proteins independently of mRNA synthesis. Indeed, mTOR is necessary
for different forms of synaptic plasticity and long-term memory (LTM) formation. However, little is known about the time
course of mTOR activation and the extracellular signals governing this process or the identity of the proteins whose
translation is regulated by this kinase, during mnemonic processing.
Methodology/Principal Findings: Here we show that consolidation of inhibitory avoidance (IA) LTM entails mTOR
activation in the dorsal hippocampus at the moment of and 3 h after training and is associated with a rapid and rapamycin-
sensitive increase in AMPA receptor GluR1 subunit expression, which was also blocked by intra-hippocampal delivery of
GluR1 antisense oligonucleotides (ASO). In addition, we found that pre- or post-training administration of function-blocking
anti-BDNF antibodies into dorsal CA1 hampered IA LTM retention, abolished the learning-induced biphasic activation of
mTOR and its readout, p70S6K and blocked GluR1 expression, indicating that BDNF is an upstream factor controlling mTOR
signaling during fear-memory consolidation. Interestingly, BDNF ASO hindered LTM retention only when given into dorsal
CA1 1 h after but not 2 h before training, suggesting that BDNF controls the biphasic requirement of mTOR during LTM
consolidation through different mechanisms: an early one involving BDNF already available at the moment of training, and a
late one, happening around 3 h post-training that needs de novo synthesis of this neurotrophin.
Conclusions/Significance: In conclusion, our findings demonstrate that: 1) mTOR-mediated mRNA translation is required for
memory consolidation during at least two restricted time windows; 2) this kinase acts downstream BDNF in the
hippocampus and; 3) it controls the increase of synaptic GluR1 necessary for memory consolidation.
Citation: Slipczuk L, Bekinschtein P, Katche C, Cammarota M, Izquierdo I, et al. (2009) BDNF Activates mTOR to Regulate GluR1 Expression Required for Memory
Formation. PLoS ONE 4(6): e6007. doi:10.1371/journal.pone.0006007
Editor: Olivier Jacques Manzoni, INSERM U862, France
Received April 22, 2009; Accepted May 27, 2009; Published June 23, 2009
Copyright:  2009 Slipczuk et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Agency of Scientific and technical Promotion of Argentina (to J.H.M.) and the National Research
Council of Brazil (to I.I. and M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jmedina@fmed.uba.ar
. These authors contributed equally to this work.
Introduction
Translational control in eukaryotic cells is critical for gene
regulation during nutrient deprivation and stress, development
and differentiation, nervous system function, aging, and disease
[1]. A prevailing view indicates that long-lasting forms of synaptic
plasticity and memory require new protein synthesis across
multiple experimental preparations and species. These plasticity-
related proteins are supposed to stabilize synaptic reinforcement
that occurs after a learning event [2–5]. However, the questions of
which proteins are translated during memory formation and which
are the signals triggered by the learning experience to regulate
such translation remain unanswered.
mTOR is a high molecular-weight serine-threonine protein
kinase that modulates cell growth, proliferation and synaptic
plasticity via the regulation of protein synthesis [6] specifically
controlling the translation of a subset of mRNAs that contain
extensive secondary structure at their 59 UTR or an oligopyr-
imidine tract in their 59 end (TOP mRNAs) [7]. This kinase can
be activated by different extracellular signals and regulates
protein synthesis at the initiation level mainly through the
phosphorylation of at least two downstream targets, p70S6
kinase (p70S6K) and eukaryotic initiation factor 4E-binding
proteins (4E-BPs, see for references, [8]). In neurons, mTOR is
present at the synaptic region where it modulates the synthesis of
locally-translated proteins, is upregulated in an activity-depen-
dent manner and is critical for different forms of synaptic
plasticity, including long-term potentiation (LTP) [9,10]. In
addition, several studies have implicated mTOR signaling in
memory processing.
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6007Rapamycin is a specific inhibitor of mTOR function that
prevents p70S6K and 4E-BPs phosphorylation thus interfering
with the initiation of translation [11] of a subset of mRNAs rather
than general translation [12]. When administered around training,
rapamycin blocks LTM formation in a number of learning tasks
[13–17]. However, little is known about the extracellular signals
triggered by training that are essential to activate mTOR for the
regulation of protein synthesis during memory consolidation.
Brain-derived neurotrophic factor (BDNF) is a member of the
family of neurotrophins intimately implicated in synaptic plasticity
and memory. BDNF is capable of inducing the late phase of long-
term potentiation even in the absence of electrical stimulation and
is not only necessary but sufficient for LTP and persistence of
LTM storage in the hippocampus [18,19]. Moreover, this protein
is required for memory formation in many learning tasks [15,20].
Given that BDNF induces rapamycin-sensitive synaptic potenti-
ation [9] and regulates translation of 59 TOP mRNA encoded
proteins at dendrites through an mTOR-dependent pathway [21],
we and others hypothesized that this neurotrophin could control
mTOR activation state during memory processing [22].
It has been previously proposed that memory consolidation and
persistence may rely on multiple waves of protein synthesis
[23,24]. For instance, a second wave of sensitivity to anisomycin, a
well-known, general protein synthesis inhibitor, has been found 3–
9 h after training in a number of learning tasks [25–29].
Therefore, the aims of the present study were firstly to examine
if a single or multiple mTOR-dependent phase(s) is/are involved
in the regulation of protein synthesis required for LTM formation,
secondly to determine whether BDNF plays a role in mTOR-
dependent regulation of LTM formation and finally to identify
plasticity-related proteins required for memory formation regulat-
ed by this pathway.
Results
Two Time Windows of mTOR Activation Are Required for
Consolidation of Inhibitory Avoidance LTM
To investigate the effect of learning on the activation of mTOR
and its downstream effector p70S6K we used a one-trial step-
down inhibitory avoidance paradigm (IA). This fear-motivated
associative learning task is hippocampus-dependent and acquired
in a single and brief training session [30–35], which makes it
suitable for investigating time-dependent mechanisms initiated by
training [15,36] without the possible interference of retrieval of the
learned response that occurs in multi-trial tasks [5,37].
Confirming and extending previous findings [15], we found that
IA training is associated with mTOR activation in the dorsal
hippocampus (Figure 1). Immunoblot analysis with an antibody
that detects mTOR only when phosphorylated at serine 2448 (p-
mTOR), i.e., when active, revealed two peaks of increased p-
mTOR immunoreactivity in the dorsal hippocampus of trained
rats sacrificed immediately (0 h) or 3 h after training (0 h: +104%
respect to naı ¨ve, p,0.001, n=5; 3 h: +148% respect to naı ¨ve,
p,0.001, n=5). On the other hand, no changes in p-mTOR
immunoreactivity were found 15 min, 1 h, 9 h or 12 h after
training. Moreover, the total amount of mTOR in trained animals
remained unaltered when compared to naı ¨ve or shocked controls.
Importantly, the IA training-induced activation of mTOR is
learning-specific since no changes in p-mTOR levels were found
in shocked control animals.
To determine the time course of mTOR activity requirement
for IA LTM formation we infused rapamycin, a highly specific
inhibitor of mTOR [38–42], into the CA1 region of the dorsal
hippocampus (Figure 2) 15 min before or at different times after
training. As can be seen in Figure 3A, rapamycin impaired LTM
retention when administered 15 min before or 3 h after training
(p,0.001, n=8–10). However, no effect was seen when
rapamycin was infused at 0 h, 1 h, 9 h, or 12 h after training,
indicating that the amnesia induced by this drug is not attributable
to impairment of retrieval or to nonspecific behavioral effects. The
impairment in LTM retention 24 h after training produced by
rapamycin was also observed in a different group of IA trained rats
tested 7 days post-training (Figure 3B), indicating that the amnesic
effect of rapamycin is long-lasting.
p70S6K is activated by phosphorylation at Thr-389 solely via
mTOR and it is widely used as a readout of mTOR activity [13–
15,21,43]. Thus, we used phospho-p70S6K (p-p70S6K) immuno-
blot to determine the effectiveness of rapamycin infusions
(Figure 3A inlet). At the dose used in the pharmacological
experiments presented above (4.3 pg/side), the intra-CA1 infusion
of rapamycin inhibited hippocampal p70S6K phosphorylation by
more than 60% (p,0.05, n=5). Indeed, when infused into dorsal
CA1 15 min before IA training, rapamycin prevented the
learning-induced phosphorylation of p70S6K observed at
15 min post-training (Vehicle=131.763.12, rapamy-
cin=92.6864.88 vs naı ¨ve animals p,0.001 in one-way ANOVA,
n=5). Moreover, when administered 2:45 h after the training
session it blocked the IA-induced increase in hippocampal p70S6K
phosphorylation levels 3 h post-training (Vehicle=141.4634.03,
rapamycin=74.51621.96 vs naı ¨ve animals p,0.01. One-way
Anova, n=6).
Together, these findings indicate that the amnesic effect of
rapamycin is long-lasting and that there are, at least, two time
windows during which rapamycin is able to induce amnesia for IA
memory: one around the time of training and the other one 3 h
later. These two periods of sensitivity to rapamycin overlap with
the two peaks of increased hippocampal p-mTOR levels observed
after IA training (Figure 1), indicating that learning of the IA
response requires mTOR activity around the time of training and
once again 3 h later.
BDNF Is an Up-Stream Activator of mTOR During Memory
Formation
Having determined the existence of two post-training windows
of mTOR activity that are necessary for IA memory consolidation,
we set to identify the extracellular signals that could be driving
mTOR biphasic activation necessary for memory processing.
Given that BDNF regulates local protein synthesis in dendrites
[21,43–45] through an mTOR-dependent pathway [21] and also
induces LTP that is blocked by rapamycin [9], we examined if
BDNF could be triggering mTOR activation during IA training.
Rats infused with function-blocking anti-BDNF antibodies into
dorsal CA1 15 min before or 3 h after IA training were amnesic
when tested 24 h post-training (Figure 4A, 4B), suggesting a role
for BDNF in mTOR pathway. Albeit function-blocking anti-
BDNF antibodies block IA memory consolidation when admin-
istered pre-training, they have no effect when injected immediately
after training [36]. Moreover, it is known that BNDF vesicles are
rapidly released in an activity dependent manner [20]. For that
reasons we wondered if the two time windows described above
were different in their need for new BDNF synthesis. We have
previously shown that BDNF oligonucleotides (BDNF ASO) block
learning-induced BDNF synthesis in the hippocampus 2 h after
injection without lowering basal BDNF levels [24]. Therefore, we
injected BDNF ASO and BDNF scrambled missense oligonucle-
otides (BDNF MSO) into the hippocampus 2 h before or 1 h after
training to inhibit BDNF synthesis around or 3 h after IA training,
respectively. We found that even though BDNF synthesis was
BDNF, mTOR, GluR1 and Memory
PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e6007Figure 1. IA Training Is Associated with Two Time Windows of mTOR Activation in the Hippocampus. Bars represent the mean p-mTOR/
mTOR ratio of trained (black) or shocked (gray) groups respect to naı ¨ve (white) group, sacrificed immediately (A), 15 min (B), 1 h (C), 3 h (D), 9 h (E) or
12 h (F) after IA training. Data are expressed as means6SEM of p-mTOR/mTOR ratio; *p,0.05, **p,0.01. Representative blots of phosphorylated and
total protein levels of mTOR are shown in the lower panels. n=5–6 per group for each experiment.
doi:10.1371/journal.pone.0006007.g001
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window (about 3 h after training, Figure 4D), it was not required
at the moment of training (Figure 4C). A feasible explanation
could be that stored, previously synthesized BDNF is released
immediately post-training during the first window, whereas new
BDNF protein has to be synthesized during the second time
window, around 3 h post-training.
Subsequently we wanted to elucidate whether BDNF was the
upstream activator of mTOR during memory consolidation. To
begin with, we decided to focus on the first window. We found that
blockade of BDNF with function-blocking anti-BDNF antibodies
delivered into dorsal CA1 15 min before training abolished the IA
learning-induced increase in mTOR (Figure 5A) and p70S6K
(Figure 5B) phosphorylation. These findings indicate that endog-
enous BDNF activates the hippocampal mTOR signaling cascade
immediately after training.
Given that the first wave of protein synthesis, which occurs
around the time of training, is the best studied regarding its
functional role on memory formation, whereas the second wave of
protein synthesis is still not well understood [46], we decided to
characterize the second window as well.
We found that injection of function-blocking anti-BDNF
antibodies 2:45 h after training hindered the IA learning-induced
increase in mTOR (Figure 5C) and p70S6K (Figure 5D)
phosphorylation that takes place 3 h after training. These results
show that BDNF is the extracellular signal triggering mTOR
activation 3 h after training.
Activation of the BDNF/mTOR Pathway Regulates GluR1
Translation Necessary for Memory Formation
What proteins relevant for memory are regulated by the
BDNF/mTOR pathway at the translational level? A likely
candidate is the GluR1 subunit of a-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA) receptors. It is known that
BDNF enhances the local translation of different glutamate
receptor subunits, particularly the GluR1 subunit of AMPA
receptor [47–49] through activation of mTOR [48] and that
Figure 2. Cannulae Placements and Drug Infusions. Schematic representations of rat brain sections at three rostrocaudal planes (23.80, 24.30,
and 24.80 from bregma) taken from the atlas of Paxinos and Watson, showing, in stippling, the extension of the area reached by the infusions in the
dorsal hippocampus. Reprinted from The Rat Brain in Stereotaxic Coordinates by Paxinos and Watson, pages 33, 35, and 37, Academic Press (1997),
with permission from Elsevier.
doi:10.1371/journal.pone.0006007.g002
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e6007Figure 3. mTOR Signaling Is Required for IA Memory Consolidation During Two Restricted Time Windows After Training. Data are
expressed as mean (6SEM) of training (TR, black bars) or test session step-down latency at 24 h (A) or 7 days (B) after IA training. Animals were
infused intra-CA1 of the dorsal hippocampus with vehicle (Vh, light grey bars) or rapamycin (4.3 pg/side, dark grey bars), 15 min before or 0, 1, 3, 9,
and 12 h after training. Inlet: Rats were infused into the dorsal hippocampus with rapamycin (4.3 pg/side) or vehicle and sacrificed 15 min after drug
infusion for analysis of p70S6K activation in the dorsal hippocampus by Western blot. Bars represent the p-p70S6K/p70S6K ratio of rapamycin (white)
respect to vehicle (black) treated rats. *p,0.05, **p,0.01, ***p,0.001 vs. Vh for each time point, n=8–10 per group for each experiment in A and B
and n=5 per group in the inlet.
doi:10.1371/journal.pone.0006007.g003
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neurons [50]. Therefore, we determined whether IA training
increases the expression of GluR1 protein levels in the dorsal
hippocampus. Extending previous findings [32,33], we found that
IA training resulted in an increase in the expression of GluR1
protein in a subcellular fraction enriched in synaptic plasma
membranes (P2) isolated from the dorsal hippocampus 15 min or
3 h after training (Figure 6A, +7569 percent respect to naı ¨ve
animals p,0.001 n=7; Figure 6B, +55611 percent respect to
naı ¨ve animals p,0.01 n=5). Furthermore this change appears to
be specific for the hippocampus, as no changes were found in the
amygdala (15 min: TR=105.567.8 respect to naı ¨ve p.0.05,
n=5 per group; 3 h: TR=110.469.1 respect to naı ¨ve p.0.05.
Student’s t test, n=5 per group). To determine whether the
BDNF/mTOR pathway regulates these increases in GluR1
protein in synaptic plasma membranes, we injected into CA1
region of the dorsal hippocampus function-blocking anti-BDNF
antibodies or rapamycin 15 min before training and sacrificed the
animals 15 min after training. Both function-blocking anti-BDNF
antibodies (Figure 6C) and rapamycin (Figure 6D) hindered the
learning-induced increase in GluR1. Furthermore, function-
blocking anti-BDNF antibodies (Figure 6E) or rapamycin
(Figure 6F) infused 2:45 after training abolished the increase in
GluR1 expression occurring 3 h after training. These experiments
indicate that the BDNF/mTOR signaling pathway controls the
learning-induced increase in GluR1 15 min or 3 h after training.
In order to elucidate whether GluR1 is necessary for memory
consolidation at the same time points during which the BDNF/
mTOR pathway is regulating its translation we infused the AMPA
receptor antagonist CNQX into the dorsal hippocampus imme-
diately, 1 h or 3 h after IA training and analyzed its effect on
retention 24 h later. As seen in Fig. 7A, CNQX hampered IA
LTM consolidation at every post-training time point analyzed.
Then, we blocked GluR1 translation during training or 3 h
thereafter by injecting GluR1 antisense oligonucleotides (GluR1
ASO) or GluR1 scrambled missense oligonucleotides (GluR1
MSO) into CA1 region of the dorsal hippocampus 2 h before or
1 h after IA training. Initially we observed that administering
GluR1 ASO 2 h before training abolished training-induced
GluR1 translation 15 min after training (Fig. 7B) and GluR1
ASO injected 1 h after training hindered training induced GluR1
translation 3 h after training (Fig. 7C). We then injected GluR1
ASO or GluR1 MSO at the time points aforementioned and
observed that inhibiting GluR1 translation at any of both time
Figure 4. Different Requirement of BDNF Activity and Synthesis During the Two Time Windows of Memory Consolidation. Data are
expressed as mean (6SEM) of training (TR, black bars) or test session step-down latency at 24 h after IA training. Animals were infused intra-CA1 of
the dorsal hippocampus with vehicle (Vh, white bars) or function-blocking anti-BDNF antibodies (1 mg/ml, grey bars) 15 min before (A) or 3 h (B) after
training. Animals were infused intra-CA1 of the dorsal hippocampus with BDNF MSO (white bar) or BDNF ASO (2 nmol/ml, 1 mg/side, grey bar), 2 h
before (C) or 1 h (D) after IA training. *p,0.05, **p,0.01, ***p,0.001 vs Vh (A, B) or MSO (C, D), n=10 per group for each experiment.
doi:10.1371/journal.pone.0006007.g004
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training (Figure 7D, E). Moreover, the effect was specific for GluR1
mRNA translation as we found no effect of GluR1 ASO on the
learning-induced increase in GluR2 protein levels measured in the
same membrane preparation (Figure 7F, G). GluR1 scramble
missense oligonucleotides did not affect GluR1 levels or memory
retention at any post-training time analysed (Figure 7B, C, D, E).
These results show for the first time, to our knowledge, that GluR1
translation is necessary around training and again 3 h later for
memory consolidation.
As a conclusion, our results show that BDNF is the upstream
activator of mTOR around training and 3 h after training to
regulate GluR1 translation in hippocampal synaptic plasma
membranes during IA training memory consolidation.
Figure 5. BDNF Triggers mTOR Activation in the Hippocampus During IA Training and 3 h Thereafter. Bars represent mean p-mTOR/
mTOR (A and C) or p-p70S6K/p70S6K ratio (B and D) of rats infused with vehicle (black), function-blocking anti-BDNF antibodies (0.5 mg/side; grey),
respect to the naı ¨ve group (white). Intra-CA1 infusion of function-blocking anti-BDNF antibodies 15 min before IA training prevents mTOR (A) and
p70S6K (B) activation immediately or 15 min after training respectively and infusion 2:45 h after training prevents mTOR (C) and p70S6K (D)
activation 3 h after training. Representative blots of phosphorylated and total protein levels of mTOR and p70S6K are shown in the lower panels.
*p,0.05, **p,0.01, n=5–6 per group for each experiment.
doi:10.1371/journal.pone.0006007.g005
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e6007Figure 6. IA Training Induces GluR1 Expression in Hippocampal Synaptic Plasma Membranes-Enriched Fractions Through BDNF/
mTOR Pathway. Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-enriched fractions obtained from samples of the
dorsal hippocampus of trained (black) respect to naı ¨ve (white) rats 15 min (A) or 3 h after IA training (B). Rats infused intra-CA1 of the dorsal
hippocampus 15 min before and sacrificed 15 min after training (B and C) or 2:45 h and sacrificed 3 h both after training (E and F) with vehicle (black)
or function-blocking anti-BDNF antibodies (0.5 mg/side; dark grey) (C and E) or rapamycin (4.3 pg/side; light grey) (D and F). Representative blots of
total GluR1 protein levels and actin are shown in the lower panels *p,0.05, **p,0.01, ***p,0.001, n=5–7 per group.
doi:10.1371/journal.pone.0006007.g006
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Despite a few theoretical interpretations against it [51,52], the
view that macromolecular synthesis is the key step in LTM
formation has been gaining more and more evidence during the
past 25 years [28,53]. However, little is known about the
extracellular signals that trigger the synthesis of specific and
essential proteins involved in the creation of LTMs. Recent
experiments show that at least some of the proteins involved in
plasticity and memory are synthesized at the synapse from pre-
existing mRNAs [54] and mTOR signaling has been found to
regulate this local translation [21,48].
The main findings of the present study are: (1) a biphasic
activation of hippocampal mTOR signaling is associated with IA
training and is required for its memory formation; (2) activation of
the mTOR cascade in the dorsal hippocampus is initiated by
BDNF; (3) previously synthesized BDNF is rapidly released
immediately after IA training whereas around 3 h after training,
new synthesis of BDNF protein is needed for LTM formation; (4)
learning related BDNF/mTOR cascade activation after training
induces GluR1 expression in hippocampal synaptic plasma
membranes; and (5) GluR1 translation during training or 3 h
later is required for IA memory consolidation.
We demonstrated the existence of two time windows, one
around training and the other 3 h thereafter, during which a
specific inhibitor of mTOR activation infused into CA1 produced
clear-cut deficits in LTM for a one-trial IA task. These two time
periods parallel those observed when the broad range protein
synthesis inhibitor anisomycin is used [27,28], and they agree with
previous findings demonstrating the existence of two critical
periods of sensitivity of different memories to protein synthesis
inhibitors [5,25–29,55]. In addition, closely related events up- or
downstream to protein synthesis also exhibited biphasic activity
after training [26,31,46,56–59]. Given that the magnitude of the
amnesic effect seen with rapamycin is quite similar to that found
with anisomycin [28] and that rapamycin decreases protein
synthesis only by 10–15% instead of 70–95% as seen with
anisomycin [13,60], the subset of transcripts whose translation is
affected by rapamycin seems to be critical for memory formation.
These results support the hypothesis that memory consolidation is
not a continuous process, but it rather relies on multiple and
recurrent waves of protein synthesis to reinforce synaptic
connections or to grow new ones [23]. These phases of protein
synthesis might have the same or different molecular signatures
[28]. It is widely accepted that rapamycin is a highly specific
inhibitor of mTOR. This is mainly due to the fact that for
rapamycin to be active biologically, it must form a ternary
complex with mTOR and FKBP12 (FK506-binding protein
12 kDa), a small cytosolic protein receptor. Rapamycin binds to
a specific domain of mTOR and FKBP12 to form a sandwich-like
structure that confers an unusually high specificity for rapamycin
[61]. However, we cannot totally rule out the possibility that
rapamycin may affect other molecular targets.
In considering the role of local protein synthesis in synaptic
plasticity underlying memory processing [21,62,63], the present
results raise several questions: What are the upstream extracellular
signals that mediate activation of mTOR signaling required for
memory formation? Which are the protein products that are
expressed during these waves of translation required for LTM
formation? We began to answer these questions by examining
whether BDNF triggers the activation of mTOR induced by IA
training.
BDNF exerts diverse roles in regulating neuronal structure and
function [64,65]. In particular, it appears to be critical for synaptic
plasticity and memory processing in the adult brain [24,36,65,66].
In fact, BDNF induces and is sufficient for long-term potentiation
(LTP) in the hippocampus [18,67–69], a form of synaptic plasticity
thought to underlie LTM [5,35,37,70]. It has been shown that
BDNF activates several molecular cascades and gene expression
pathways; however it is not clear which of the intracellular
effectors of this activation are important for memory consolida-
tion.
Here we showed that function-blocking anti-BDNF antibodies
infused into the dorsal hippocampus 15 min before or 3 h after IA
training, a treatment that impairs formation of avoidance memory,
hinder the IA training-induced activation of hippocampal mTOR.
We then showed that the two windows of necessity for BDNF
differ in their need for new BDNF synthesis. While previously
synthesized stored BDNF would be enough around training, new
BDNF has to be synthesized about 3 h after training. This finding
is consistent with others showing an increase of BDNF mRNA in
CA1 of the hippocampus 1 h after IA training [36] or within 2–
4 hs after application of L-LTP-inducing tetanic stimulation [71].
During training, pre-existing proBDNF could be rapidly cleaved
to BDNF by tPA in the absence of de novo transcription or
translation [18]. Despite other results showing a different effect for
pre-training BDNF ASO [72], these differences could be
explained by the fact that distinct training procedures and shock
intensities induce different molecular activation kinetics [26].
Having established that BDNF is an up-stream activator of
mTOR, we then focused our attention on proteins germane to
learning, whose translation is regulated by the BDNF/mTOR
pathway during plastic processes such as LTP. A likely candidate is
the GluR1 subunit of AMPA receptors [73–75]. We found that
rapamycin and function blocking anti-BDNF antibodies infused
into the dorsal hippocampus 15 min before or 2:45 h after IA
training, prevent the rapid increase in GluR1 protein induced by
IA training necessary for memory consolidation. Our findings are
consistent with others showing that, in vitro, BDNF upregulates
local translation of PSD95 through mTOR pathway [76] and
enhances the expression of GluR1 subunit of AMPA receptors via
activation of mTOR [48]. These results are important for two
Figure 7. GluR1 Translation Is Required for IA Memory Consolidation During Training and 3 h Thereafter. (A) Animals were injected
with Vehicle (black bar) or CNQX immediately, 1 h or 3 h after IA training (grey bars). Data are expressed as mean (6SEM) of training (TR, white bars)
or test session step-down latency at 24 h after IA training. (B and C) Bars represent the mean GluR1/actin ratio from synaptic plasma membranes-
enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR (grey bar) or
MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C). (D and E) Animals
were injected with MSO (black bar) or GluR1 ASO (grey bar) 2 h pre-TR (D) or 1 h after TR (E). Data are expressed as mean (6SEM) of training (TR,
white bars) or test session step-down latency at 24 h after IA training. (F and G) Bars represent the mean GluR2/actin ratio from synaptic plasma
membranes-enriched fractions obtained from samples of the dorsal hippocampus of animals trained in IA and injected with GluR1 ASO 2 h pre-TR
(grey bar) or MSO (black bar) and sacrificed 15 min after TR (B) or injected with GluR1 ASO 1 h after TR or MSO and sacrificed 3 h after TR (C).
*p,0.05, **p,0.01, ***p,0.001, n=10–14 per group for each experiment in figures A, D and E; n=5 per group for each experiment in figures B, C, F
and G.
doi:10.1371/journal.pone.0006007.g007
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unleashes protein synthesis-dependent memory consolidation in
the hippocampus as has been previously proposed [20]. Second,
they demonstrate that one of the main effects of BDNF action
during memory formation is to increase the expression of GluR1
in synaptic membranes, and that it does so by activating the
translation machinery through the engagement of mTOR and its
downstream target p70S6K. Although processes other than
translation could be associated to the increase in GluR1
expression, so far, the regulation of protein synthesis has been
the only mechanism in which mTOR has been implicated. In
addition, GluR1 ASO hinders the BDNF/mTOR dependent
increase in GluR1 in synaptic plasma membranes and causes a
clear-cut LTM deficit 24 h after training. Moreover, we and
others have reported that a rapid post-training increase in GluR1
occurs as a consequence of an augmented protein synthesis in
addition to translocation form other sub-cellular compartments
[33,48]. Furthermore, it has been shown that dopaminergic
stimulation of hippocampal neurons leads to a rapid increase in
dendritic expression of GluR1 subunit through a mechanism that
requires protein synthesis [77]. It has been shown that GluR1
mRNA can be transported into dendrites in response to neuronal
activity [78], where it can undergo activity-dependent translation
at the base of or within spines [79]. Importantly, polyribosomes
and other components or regulators of the translational machin-
ery, including mTOR and its downstream targets S6K and 4E-BP
have also been reported to be present in spines and dendritic shafts
[80,81]. Alternatively, albeit the rapid increase in GluR1 levels
induced by IA training in a synaptic plasma membrane-enriched
subcellular fraction may reflect an enhancement in trafficking and
membrane insertion of already formed GluR1 subunits [73,74], it
is unlikely that this is the only mechanism, for the afore mentioned
reasons. Nevertheless, if this was the case, then our findings could
imply that mTOR activation regulates translation of proteins
necessary for trafficking and insertion of synaptic receptors. This
alternative view deserves further studies.
Together, our findings show that the activated BDNF/mTOR
pathway induced expression of GluR1 AMPA receptor subunit in
hippocampus synaptic membranes, a key effector protein involved
in stabilization of the memory traces is critical for LTM formation.
Materials and Methods
Ethics Statement
The experimental protocol for this study followed the guidelines
of the USA National Institutes of Health Guide for the Care and
Use of Laboratory Animals and was approved by the Animal Care
and Use Committees of the University of Buenos Aires.
Subjects
Male adult Wistar rats (weight, 200–250 g) were housed five to
a cage and kept with water and food ad libitum under a 12 h light/
dark cycle (lights on at 7 A.M.) at a constant temperature of 23uC.
Experiments took place during the light phase of the cycle.
Behavioural Procedures
Animals were allowed to acclimate to the laboratory for 7 days
before any experimental manipulation. Inhibitory avoidance was
performed as described previously [31]. Briefly, rats were placed
on a 5.0 cm high, 8.0 cm wide platform at left of a
50.0625.0625.0 cm white acrylic training apparatus, whose floor
was a series of parallel 0.2 cm caliber bronze bars spaced 1.0 cm
apart. Latency to step down to the grid with the four paws was
hand-scored measured. In the training trial the animals received a
0.7 mA, 3 sec scrambled foot shock immediately after stepping-
down to the grid. The retention test session was carried out 24 h
(LTM) or 7 days after training. This session was procedurally
identical to the training session, except that the foot-shock was
omitted. All the experiments were realised blinded to the
experimental group.
Surgery and Infusion Procedures
Rats were implanted under thionembutal anesthesia with 22-
g guide cannulae in the CA1 region of the dorsal hippocampus
at coordinates A24.3, L63.0, V21.4 of the atlas by Paxinos
and Watson [82]. The cannulae were fixed to the skull with
dental acrylic. Cannulated rats received bilateral intra-CA1
0.5 ml infusions 15 min before or immediately, 1 h, 3 h, 9 h, or
12 h after training. Rapamycin (4.3 pg/side; Cell Signaling,
Danvers, MA) was dissolved in 0.1% dimethyl sulfoxide
(DMSO). The function-blocking anti-BDNF antibodies (Che-
micon, Temecula, CA; AB1513P) were diluted to working
concentration (1 mg/ml) with saline. Oligonucleotides (ODN;
Genbiotech S.R.L.) were HPLC-purified phosphorothioate end-
capped 18-mer sequences, resuspended in sterile saline to a
concentration of 2 nmol/ml. Both ODNs were phosphor-
othioated on the three terminal bases of both 59 and 39 ends.
This modification results in increased stability and less toxicity of
the ODN. BDNF ASO, 59 -TCTTCCCCTTTTAATGGT- 39;
BDNF MSO, 59 -ATACTTTCTGTTCTTGCC- 39. GluR1 ASO,
59 -TAAGCATCACGTAAGGATC- 39;G l u R 1M S O5 9 -A G C G -
TATCACAGTATAGAC- 39. ODN sequences were subjected to a
BLAST search on the National Center for Biotechnology Informa-
tion BLAST server using the Genbank database. BDNF ASO and
GluR1 ASO are specific for rat BDNF mRNA and GluR1 mRNA
respectively [24,83]. Control MSO sequences, which included the
same number of nucleotides than the ASO but ina scrambled order,
did not generate any full matches to identified gene sequences in the
database.
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 0.5 mg/side;
Sigma, St Louis, MO, USA) was dissolved in 2% DMSO The
infusion procedure was performed as described previously [36].
Briefly, infusions were in all cases bilateral and had a volume of
0.5 ml, except for ASO and MSO where the volume injected was
1 ml. The entire infusion procedure took around 2 min, including
45 sec for the infusions themselves, first on one side and then on
the other, and the handling. Histological examination of cannulae
placements was performed as described previously [31]. Briefly,
24 h after the end of the behavioral procedures, 0.8 mlo fa
solution of 4% methylene blue in saline was infused as indicated
above into each implanted site. Animals were killed by
decapitation 15 min later and the brains were stored in formalin
for histological localization of the infusion sites. Infusions spread
with a radius of less than 1.0 mm
3, as described before [31] and
were found to be correct (i.e., within 1.5 mm
3 of the intended site)
in 95% of the animals. Only the behavioral data from animals
with the cannulae located in the intended site were included in the
final analysis.
Biochemical Procedures
The animals utilized in the biochemical experiments were
divided in three experimental groups: 1) animals trained in the
inhibitory avoidance task and killed at different times after training
(Trained group, T); 2) animals that received a foot-shock identical
to that given to the trained ones but were not submitted to the IA
training procedure (the platform was not inside the box, and the
animals were put directly over the grid) and killed at the same time
points than the trained group (Shocked group, S); and 3) animals
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other two groups and killed immediately thereafter (Naı ¨ve group,
N); The dorsal hippocampus was dissected out and rapidly
homogenized in ice-chilled buffer (20 mM Tris-HCl (pH 7.4),
0.32 M sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF,
10 mg/ml aprotinin, 15 mg/ml leupeptin, 50 mM NaF and 1 mM
sodium) as described previously [36]. Samples of the homogenates
(30 mg of protein) were subjected to SDS–PAGE under reducing
conditions. After that, proteins were electrotransferred to PVDF
membranes which were then blocked and incubated with anti-
phospho-mTOR Ser 2448 (1:2000, Cell Signaling, Danvers, MA),
anti-mTOR (1:2000, Cell Signaling, Danvers, MA), anti-phospho-
p70S6K Thr 389 (1:2000, Cell Signaling, Danvers, MA) and anti-
p70S6K (1:2000, Cell Signaling, Danvers, MA). To analyze the
effect of mTOR and BDNF inhibition on GluR1 expression levels,
IA-trained rats received bilateral intra-CA1 infusions of rapamycin
(4.3 pg/side), anti-BDNF (0.5 ug/side) or saline 15 min before
training and were killed by decapitation 15 min thereafter. The
hippocampus was dissected out and homogenized as indicated
above except that 2 ml of the total homogenate were centrifuged
10 min at 9006g and the supernatant thus obtained was further
centrifuged 25 min at 160006g to obtain a crude sinaptosomal
fraction containing the synaptic membranes (Pellet 2; P2) that was
resuspended in 300 ml of 20 mM Tris-HCl, pH 7.4, containing
1 mM PMSF, 50 mM NaF and 1 mM sodium orthovanadate.
Samples were processed as indicated above and the PVDF
membranes were incubated with the following antibodies: anti-
GluR1 (1:1000, Santa Cruz Biotechnology Inc, Santa Cruz, CA);
anti-GluR2 (1:1000, Santa Cruz Biotechnology Inc, Santa Cruz,
CA); anti-actin (1:10000, Santa Cruz Biotechnology Inc, Santa
Cruz, CA.)
Data Analysis
Behavioral and biochemical data were analyzed by one-way
ANOVA followed by Newman–Keuls multiple comparison test or
Student’s t test when only two groups where compared.
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